Substance
TOFACITINIB CITRATE
Global reference: every product and company linked to this substance.
- cas: 540737-29-9
- ncit: C95801
- pubchem_cid: 10174505
- rxnorm: 1358492
- unii: O1FF4DIV0D
CP-690 · CP-690,550-10 · CP-690550 CITRATE · CP-690550-10 · TOFACITINIB CITRATE [JAN] · TOFACITINIB CITRATE [USAN] · Tofacitinib citrate [WHO-DD] · XELJANZ · XELJANZ XR
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| PFIZER INC. COMMON STOCK | XELJANZ | Q2 2026 | $251.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (3)
- TOFACITINIB CITRATE · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
- XELJANZ · PFIZER INC. COMMON STOCK
- XELJANZ XR · PFIZER INC. COMMON STOCK